Practical considerations for pharmacogenetic testing.
Wedlund
P J
PJ
D003362:Cost-Benefit Analysis; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism; D004358:Drug Therapy / Q000592:standards; D004496:Education, Continuing; D005820:Genetic Testing / Q000191:economics*; D006801:Humans; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism; D010597:Pharmacogenetics / Q000191:economics*; D011110:Polymorphism, Genetic; D016896:Treatment Outcome; D014481:United States
D019389:Cytochrome P-450 CYP2D6; D008780:Methyltransferases; C022745:thiopurine methyltransferase